Prior cohort and registry studies have reported that lower Hb on admission is associated with larger infarct size, greater early neurological deficit and worse global functional outcome or mortality after ischemic stroke (Khan et al., 2018; Hao et al., 2013; Ceulemans et al., 2024). Here, GSTM1 is linked to ischemic stroke.